- Type
- Packaging monomer
- How serious
- Moderate severity
- Evidence
- Moderate evidence
Why it is flagged
Shares BPA's oestrogenic mechanism at comparable potency in laboratory assays, so the substitution may not reduce hormonal exposure.
Health topics it bears on
Sources
- Bisphenol analogues in people living in Canada Health Canada, 2026
- Candidate List of substances of very high concern for Authorisation: 4,4'-sulphonyldiphenol European Chemicals Agency, 2023
Also listed as
bps, 4,4'-sulfonyldiphenol